Chronic Limb-Threatening Ischemia: Clinical Trials

5 trials for Chronic Limb-Threatening Ischemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 unknown, 1 recruiting. 5 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 15Completed 2, Unknown 2, Recruiting 1

Follow Chronic Limb-Threatening Ischemia: new trials by email Literature Review of Chronic Limb-Threatening Ischemia trials Research Report on Chronic Limb-Threatening Ischemia

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety, Tolerability, and Biodistribution of [89Zr]Zr-DFO-APAC in Subjects With PAOD/CLI and Healthy Volunteers (Acronyms: 89Zr = Zirconium-89, DFO = Desferrioxamine, APAC = AntiPlatelet AntiCoagulant, PET/CT = Positron Emission Tomography/Computed Tomography)
[89Zr]Zr-DFO-APAC, PET/CT scan - Peripheral Arterial Occlusive Disease, Critical Limb Ischemia
Early Phase 1UnknownAplagon Oy102024-02-012025-01-30
Umbilical Cord Artery-derived Perivascular Stem Cells for the Critical Limb Ischemia Therapy
UCA-PSCs/bFGF or bFGF Intramuscular injection - Critical Limb Ischemia
Early Phase 1UnknownNanjing University402023-06-302023-12-18
Nutrition in Patient With Critical Limb Ischemia
Ensure Surgery Immunonutrition Shake, Ensure Enlive Advanced Nutrition Shake - Critical Limb Ischemia, Malnutrition
Early Phase 1RecruitingBoston Medical Center302018-10-022026-09-29
N-Acetyl-Cysteine (NAC) for Healing of Amputation Stumps in the Setting of Diabetes
Active Arm N-acetyl cysteine (NAC), Placebo Arm - Diabetes Mellitus, Critical Limb Ischemia
Early Phase 1CompletedWashington University School of Medicine332017-03-012024-08-16
Chelation Therapy in Diabetic Patients With Critical Limb Ischemia
disodium EDTA - Critical Limb Ischemia, Peripheral Arterial Disease
Early Phase 1CompletedMt. Sinai Medical Center, Miami112015-08-012019-06-10

Narrower conditions

Peripheral Arterial Disease (2)  ·  Diabetes Mellitus (1)  ·  Malnutrition (1)  ·  Peripheral Arterial Occlusive Disease 1 (1)

Broader conditions

Arterial Occlusive Diseases (5)  ·  Arteriosclerosis (5)  ·  Atherosclerosis (5)  ·  Cardiovascular Diseases (5)  ·  Chronic Disease (5)  ·  Disease Attributes (5)  ·  Ischemia (5)  ·  Pathologic Processes (5)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Peripheral Vascular Diseases (5)  ·  Vascular Diseases (5)  ·  Peripheral Arterial Disease (3)  ·  Nutritional and Metabolic Diseases (2)  ·  Endocrine System Diseases (1)  ·  Glucose Metabolism Disorders (1)

Interventions

Acetylcysteine (1)  ·  Chelation Therapy (1)  ·  Edetic Acid (1)

Sponsors

Aplagon Oy (1)  ·  Boston Medical Center (1)  ·  Mt. Sinai Medical Center, Miami (1)  ·  Nanjing University (1)  ·  Washington University School of Medicine (1)

Countries

United States (3)  ·  China (1)  ·  Netherlands (1)

Top investigators

Gervasio Lamas, MD (1)  ·  Haiming Xia, phD (1)  ·  Jeffrey J Siracuse, MD (1)  ·  Mohamed Zayed, MD (1)  ·  Schelto Kruijff, MD, Prof (1)

Results publications

PMID 35129469

NIH funding

2023 (1)